Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Indofarma Tbk. (INAF) vs Mahkota Group Tbk. (MGRO)

Indofarma Tbk.Trading
Mahkota Group Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Indofarma Tbk. dan Mahkota Group Tbk.: Indofarma Tbk. diperdagangkan di Rp126 (kapitalisasi pasar 390,51 M), sedangkan Mahkota Group Tbk. diperdagangkan di Rp685 (kapitalisasi pasar 2,42 T, volume 24 jam 3,54 jt). Perbedaan utamanya: Mahkota Group Tbk. jauh lebih besar — sekitar 6,2× kapitalisasi pasar Indofarma Tbk.. Mana yang lebih baik tergantung tujuan investasimu.

INAFMGRO
Kapitalisasi Pasar
390,51 M2,42 T
Volume
3,54 jt
Lot
35,4 rb
Perputaran
2,4 M
Harga Rata-rata
679,25
Nilai Transaksi
2,4 M
Harga Ekuilibrium Indikatif
685
Volume Ekuilibrium Indikatif
2

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

INAF
Lihat detail
MGRO
Lihat detail

Tentang Indofarma Tbk.

PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.

Selengkapnya di halaman INAF

Tentang Mahkota Group Tbk.

PT Mahkota Group (the Company) was established based on Deed No. 7 dated January 7, 2011 of Cipto Soenaryo, S.H., Notary in Medan.

Selengkapnya di halaman MGRO